Skip to main content
OpenTrials

Clinical trial condition

Primary Hyperoxaluria

Explore clinical trials studying Primary Hyperoxaluria. Study availability and eligibility vary by location and protocol.

19 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Primary Hyperoxaluria trial results

Recruiting

Rare Kidney Stone Consortium Patient Registry

NCT00588562

Conditions
APRT Deficiency, Adenine phosphoribosyltransferase deficiency, Carbohydrate Metabolism, Inborn Errors, +19 more
Locations
  • Dent Disease Registry -Mayo Clinic Rochester, Minnesota, United States
  • Primary Hyperoxaluria Registry - Mayo Clinic Rochester, Minnesota, United States
  • Cystinuria Registry - New York University New York, United States
  • APRT Registry - Landspitali Universtiy Hospital Reykjavik, Iceland
View Trial Details
Completed

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

NCT05001269

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +17 more
Locations
  • Clinical Research Site Rochester, Minnesota, United States
  • Clinical Research Site Hamilton, Ontario, Canada
  • Clinical Trial Site Bonn, Germany
  • Clinical Research Site Heidelberg, Germany
View all 13 locations
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details
Completed

A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

NCT04152200

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site Houston, Texas, United States
  • Clinical Trial Site Garran, Australia
  • Clinical Trial Site Brussels, Belgium
View all 14 locations
View Trial Details
Completed

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1

NCT03905694

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site Houston, Texas, United States
  • Clinical Trial Site Lyon, France
  • Clinical Trial Site Paris, France
View Trial Details
Completed

Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria

NCT03392896

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +12 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Centre d'Investigation Clinique - CIC 1407 - Hospices Civils de Lyon Bron, France
  • Universitätsklinikum Bonn-Institut für Klinische Chemie und Klinische Pharmakologie Bonn, Germany
  • University of Amsterdam Amsterdam, Netherlands
View Trial Details
Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

NCT03350451

Conditions
AGT, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations
  • Clinical Trial Site Bordeaux, France
  • Clinical Trial Site Lyon, France
  • Clinical Trial Site Paris, France
  • Clinical Trial Site Bonn, Germany
View Trial Details
Completed

Health-related Quality of Life in Rare Kidney Stone

NCT02124395

Conditions
Adenine Phosphoribosyl Transferase Deficiency, Adenine phosphoribosyltransferase deficiency, Carbohydrate Metabolism, Inborn Errors, +19 more
Locations
  • Primary Hyperoxaluria and Dent Disease Registry - Mayo Clinic Rochester, Minnesota, United States
  • New York University School of Medicine - Cystinuria Registry New York, United States
  • APRT Registry - Landspitali Universtiy Hospital Reykjavik, Iceland
View Trial Details

Related conditions